Celemics is a South Korean company that focuses on the development and production of target enrichment panels based on hybridization capture technology. Celemics is just starting out in the European market and offers an uncompromisingly nice price/performance ratio, reliability and personal approach to customers. Target enrichment panels from Celemics are widely used in clinical diagnostics and basic research and have been cited in numerous scientific articles in impacted journals.